Literature DB >> 29269089

Infectious complications associated with the use of immune checkpoint inhibitors in oncology: reactivation of tuberculosis after anti PD-1 treatment.

H Picchi1, C Mateus2, C Chouaid3, B Besse4, A Marabelle5, J M Michot6, S Champiat5, A L Voisin7, O Lambotte8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29269089     DOI： 10.1016/j.cmi.2017.12.003

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN： 1198-743X            Impact factor:   8.067


× No keyword cloud information.
  44 in total

1.  Diagnosis and management of pulmonary toxicity associated with cancer immunotherapy.

Authors:  Sawsan Rashdan; John D Minna; David E Gerber
Journal:  Lancet Respir Med       Date:  2018-06       Impact factor: 30.700

Review 2.  ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Immune checkpoint inhibitors, cell adhesion inhibitors, sphingosine-1-phosphate receptor modulators and proteasome inhibitors).

Authors:  G Redelman-Sidi; O Michielin; C Cervera; C Ribi; J M Aguado; M Fernández-Ruiz; O Manuel
Journal:  Clin Microbiol Infect       Date:  2018-02-07       Impact factor: 8.067

Review 3.  Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.

Authors:  Joshua S Davis; David Ferreira; Emma Paige; Craig Gedye; Michael Boyle
Journal:  Clin Microbiol Rev       Date:  2020-06-10       Impact factor: 26.132

4.  Severe cytomegalovirus gastritis after pembrolizumab in a patient with melanoma.

Authors:  H Kim; S Y Ha; J Kim; M Kang; J Lee
Journal:  Curr Oncol       Date:  2020-08-01       Impact factor: 3.677

5.  Active and latent tuberculosis infections in patients treated with immune checkpoint inhibitors in a non-endemic tuberculosis area.

Authors:  Gregory R Stroh; Tobias Peikert; Patricio Escalante
Journal:  Cancer Immunol Immunother       Date:  2021-03-26       Impact factor: 6.968

6.  Mycobacterium avium complex lung disease in a patient treated with an immune checkpoint inhibitor: A case report.

Authors:  Yusuke Yamaba; Osamu Takakuwa; Yusaku Tomita; Sota Owaki; Kazuki Yamada; Eiji Kunii; Yutaka Ito; Kyoji Senoo; Kenji Akita
Journal:  Mol Clin Oncol       Date:  2021-12-17

7.  PD-1 blockade exacerbates Mycobacterium tuberculosis infection in rhesus macaques.

Authors:  Keith D Kauffman; Shunsuke Sakai; Nickiana E Lora; Sivaranjani Namasivayam; Paul J Baker; Olena Kamenyeva; Taylor W Foreman; Christine E Nelson; Deivide Oliveira-de-Souza; Caian L Vinhaes; Ziv Yaniv; Cecilia S Lindestam Arleham; Alessandro Sette; Gordon J Freeman; Rashida Moore; Alan Sher; Katrin D Mayer-Barber; Bruno B Andrade; Juraj Kabat; Laura E Via; Daniel L Barber
Journal:  Sci Immunol       Date:  2021-01-15

8.  Inherited PD-1 deficiency underlies tuberculosis and autoimmunity in a child.

Authors:  Silvia Vilarinho; Richard P Lifton; Bertrand Boisson; Laurent Abel; Dusan Bogunovic; Nico Marr; Luigi D Notarangelo; Stuart G Tangye; Tasuku Honjo; Philippe Gros; Stéphanie Boisson-Dupuis; Jean-Laurent Casanova; Masato Ogishi; Rui Yang; Caner Aytekin; David Langlais; Mathieu Bourgey; Taushif Khan; Fatima Al Ali; Mahbuba Rahman; Ottavia M Delmonte; Maya Chrabieh; Peng Zhang; Conor Gruber; Simon J Pelham; András N Spaan; Jérémie Rosain; Wei-Te Lei; Scott Drutman; Matthew D Hellmann; Margaret K Callahan; Matthew Adamow; Phillip Wong; Jedd D Wolchok; Geetha Rao; Cindy S Ma; Yuka Nakajima; Tomonori Yaguchi; Kenji Chamoto; Samuel C Williams; Jean-Francois Emile; Flore Rozenberg; Michael S Glickman; Franck Rapaport; Gaspard Kerner; Garrett Allington; Ilhan Tezcan; Deniz Cagdas; Ferda O Hosnut; Figen Dogu; Aydan Ikinciogullari; V Koneti Rao; Leena Kainulainen; Vivien Béziat; Jacinta Bustamante
Journal:  Nat Med       Date:  2021-06-28       Impact factor: 53.440

Review 9.  The dark side of immunotherapy.

Authors:  Nwanneka Okwundu; Douglas Grossman; Siwen Hu-Lieskovan; Kenneth F Grossmann; Umang Swami
Journal:  Ann Transl Med       Date:  2021-06

10.  Ganglionar tuberculosis infection evolving to hemophagocytic lymphohistiocytosis after anti-programmed cell death 1 treatment for high-risk melanoma: a case report.

Authors:  Cesar M Costa; Luiza L Gadotti; Maria C Seiwald; Alessandra C R Salgues; Fernando Ganem; Ellen C T Nascimento; David E Uip; Celso Arrais-Rodrigues; Rodrigo R Munhoz
Journal:  J Med Case Rep       Date:  2021-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.